Corteva, Inc. firmly opposes efforts by several State Attorneys General to block its planned separation into two companies, emphasizing that the split will create stronger, innovation-driven leaders in agriculture. The company denies any wrongdoing related to alleged PFAS liabilities, stating these claims are speculative and unproven, and highlights its strong financial position to cover any potential liabilities. Corteva insists the separation will better serve farmers and shareholders by allowing each new company to focus on its specific business model. The company plans to vigorously defend its decision and proceed with the separation as intended.
Corteva's recent corporate developments provide context for market watchers. For readers following Basic Materials, here is Pluang's market snapshot as of Sep 15, 2026 06:12 WIB: out of 32 priced US stocks, 2 rose and 30 fell. Notable movers include FMC at USD 11.09 (-2.72%), Barrick Gold Corp at USD 42.50 (-2.70%), and Southern Copper Corp at USD 188.42 (-2.62%).
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
